Maternal death following cardiopulmonary collapse after delivery: Amniotic fluid embolism or septic shock due to intrauterine infection?

American Journal of Reproductive Immunology

Volumn 64, Issue 2, 2010, Pages 113-125

  Romero, Roberto ^a,b,c   Kadar, Nicholas ^d   Vaisbuch, Edi ^a,b   Hassan, Sonia S ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HUTZEL HOSPITAL   (United States)

^d Wayne State University School of Medicine Department of Obstetrics and Gynecology ^*

Author keywords

Bacteremia; Cardiorespiratory arrest; Chorioamnionitis; Disseminated intravascular coagulation; Fever; Intraamniotic infection; Pregnancy; Preterm labor; Tumor necrosis factor

Indexed keywords

AMPICILLIN; BETAMETHASONE; CARBOPROST; CLINDAMYCIN; DOPAMINE; ERYTHROMYCIN; FRESH FROZEN PLASMA; FUROSEMIDE; GENTAMICIN; HYDROCORTISONE; INDOMETACIN; MAGNESIUM SULFATE; METHYLERGOMETRINE MALEATE; NORADRENALIN; OXYTOCIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AMNION FLUID EMBOLISM; ANTIBIOTIC THERAPY; ARTICLE; ASTHMA; CARDIOPULMONARY COLLAPSE; CASE REPORT; CESAREAN SECTION; CHORIOAMNIONITIS; DISSEMINATED INTRAVASCULAR CLOTTING; DYSPNEA; ERYTHROCYTE TRANSFUSION; FEMALE; FETUS DISTRESS; FEVER; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; INFLAMMATION; INTRAUTERINE INFECTION; LABOR; LUNG EDEMA; MATERNAL MORTALITY; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; RESPIRATORY FAILURE; SEPTIC SHOCK; TACHYCARDIA; TACHYPNEA; UTERUS BLEEDING; VACUUM EXTRACTION; BLOOD; COMPLICATION; DIFFERENTIAL DIAGNOSIS; DISSEMINATED INTRAVASCULAR COAGULATION; EMBOLISM, AMNIOTIC FLUID; FATALITY; MECONIUM; PATHOPHYSIOLOGY; PREGNANCY; PUERPERIUM; SEPSIS; SHOCK; SHOCK, SEPTIC;

ADULT; CHORIOAMNIONITIS; DIAGNOSIS, DIFFERENTIAL; DISSEMINATED INTRAVASCULAR COAGULATION; EMBOLISM, AMNIOTIC FLUID; FATAL OUTCOME; FEMALE; HUMANS; MECONIUM; POSTPARTUM PERIOD; PREGNANCY; SEPSIS; SHOCK; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77958082868     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2010.00823.x     Document Type: Article

References (134)

1. Clark SL: New concepts of amniotic fluid embolism: a review. Obstet Gynecol Surv 1990; 45:360-368.
2. Clark SL, Hankins GD, Dudley DA, Dildy GA, Porter TF: Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol 1995; 172:1158-1167.
3. Benson MD: Anaphylactoid syndrome of pregnancy. Am J Obstet Gynecol 1996; 175:749.
4. Benson MD, Lindberg RE: Amniotic fluid embolism, anaphylaxis, and tryptase. Am J Obstet Gynecol 1996; 175:737.
5. Meyer JR: Embolia pulmonar Amnio-Caseosa. Brazil-Med 1926; 2:301-303.
6. Steiner PE, Lushbaugh CC: Maternal pulmonary embolism by amniotic fluid as a cause of obstetric shock and unexpected deaths in obstetrics. JAMA 1941; 117:1245-1254.
7. Steiner PE, Lushbaugh CC, Frank H: Fatal obstetric shock from pulmonary emboli of amniotic fluid. Am J Obstet Gynecol 1949; 58:802-805.
8. Debets JM, Kampmeijer R, van der Linden MP, Buurman WA, van der Linden CJ: Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med 1989; 17:489-494.
9. Waage A, Halstensen A, Espevik T: Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987; 1:355-357.
10. Schaerf RH, de Campo T, Civetta JM: Hemodynamic alterations and rapid diagnosis in a case of amniotic-fluid embolus. Anesthesiology 1977; 46:155-157.
11. Masson RG, Ruggieri J, Siddiqui MM: Amniotic fluid embolism: definitive diagnosis in a survivor. Am Rev Respir Dis 1979; 120:187-192.
12. Dolyniuk M, Orfei E, Vania H, Karlman R, Tomich P: Rapid diagnosis of amniotic fluid embolism. Obstet Gynecol 1983; 61:28S-30S.
13. Duff P, Engelsgjerd B, Zingery LW, Huff RW, Montiel MM: Hemodynamic observations in a patient with intrapartum amniotic fluid embolism. Am J Obstet Gynecol 1983; 146:112-115.
14. Clark SL, Montz FJ, Phelan JP: Hemodynamic alterations associated with amniotic fluid embolism: a reappraisal. Am J Obstet Gynecol 1985; 151: 617-621.
15. Clark SL: Amniotic fluid embolism. Clin Perinatol 1986; 13:801-811.
16. Clark SL, Cotton DB, Gonik B, Greenspoon J, Phelan JP: Central hemodynamic alterations in amniotic fluid embolism. Am J Obstet Gynecol 1988; 158: 1124-1126.
17. Shechtman M, Ziser A, Markovits R, Rozenberg B: Amniotic fluid embolism: early findings of transesophageal echocardiography. Anesth Analg 1999; 89:1456-1458.
18. Stanten RD, Iverson LI, Daugharty TM, Lovett SM, Terry C, Blumenstock E: Amniotic fluid embolism causing catastrophic pulmonary vasoconstriction: diagnosis by transesophageal echocardiogram and treatment by cardiopulmonary bypass. Obstet Gynecol 2003; 102:496-498.
19. James CF, Feinglass NG, Menke DM, Grinton SF, Papadimos TJ: Massive amniotic fluid embolism: diagnosis aided by emergency transesophageal echocardiography. Int J Obstet Anesth 2004; 13: 279-283.
20. Conde-Agudelo A, Romero R: Amniotic fluid embolism: an evidence-based review. Am J Obstet Gynecol 2009; 201:445.e1-e13.
21. Romero R, Mazor M, Wu YK, Sirtori M, Oyarzun E, Mitchell MD, Hobbins JC: Infection in the pathogenesis of preterm labor. Semin Perinatol 1988; 12:262-279.
22. Romero R, Mazor M, Wu YK, Avila C, Oyarzun E, Mitchell MD: Bacterial endotoxin and tumor necrosis factor stimulate prostaglandin production by human decidua. Prostaglandins Leukot Essent Fatty Acids 1989; 37:183-186.
23. Romero R, Mazor M, Manogue K, Oyarzun E, Cerami A: Human decidua: a source of cachectin-tumor necrosis factor. Eur J Obstet Gynecol Reprod Biol 1991; 41:123-127.
24. Fidel PL Jr, Romero R, Ramirez M, Cutright J, Edwin SS, LaMarche S, Cotton DB, Mitchell MD: Interleukin-receptor antagonist (IL-1ra) production by human amnion, chorion, and decidua. Am J Reprod Immunol 1994; 32:1-7.
25. Weiner AE, Reid DE: The pathogenesis of amniotic-fluid embolism. III. Coagulant activity of amniotic fluid. N Engl J Med 1950; 243:597-598.
26. Clark SL, Pavlova Z, Greenspoon J, Horenstein J, Phelan JP: Squamous cells in the maternal pulmonary circulation. Am J Obstet Gynecol 1986; 154:104-106.
27. Attwood HD: A histological study of experimental aminotic-fluid and meconium embolism in dogs. J Pathol Bacteriol 1964; 88:285-290.
28. Attwood HD, Downing ES: Experimental amniotic fluid and meconium embolism. Surg Gynecol Obstet 1965; 120:255-262.
29. Reis RL, Pierce WS, Behrendt DM: Hemodynamic effects of amniotic fluid embolism. Surg Gynecol Obstet 1969; 129:45-48.
30. Hankins GD, Snyder RR, Clark SL, Schwartz L, Patterson WR, Butzin CA: Acute hemodynamic and respiratory effects of amniotic fluid embolism in the pregnant goat model. Am J Obstet Gynecol 1993; 168:1113-1129.
31. Hankins GD, Snyder R, Dinh T, Van Hook J, Clark S, Vandelan A: Documentation of amniotic fluid embolism via lung histopathology. Fact or fiction? J Reprod Med 2002; 47:1021-1024.
32. Stolte L, van KH, Seelen J, Eskes T, Wagatsuma T: Failure to produce the syndrome of amniotic fluid embolism by infusion of amniotic fluid and meconium into monkeys. Am J Obstet Gynecol 1967; 98:694-697.
33. Adamsons K, Mueller-Heubach E, Myers RE: The innocuousness of amniotic fluid infusion in the pregnant rhesus monkey. Am J Obstet Gynecol 1971; 109:977-984.
34. Farrar SC, Gherman RB: Serum tryptase analysis in a woman with amniotic fluid embolism. A case report. J Reprod Med 2001; 46:926-928.
35. Nishio H, Matsui K, Miyazaki T, Tamura A, Iwata M, Suzuki K: A fatal case of amniotic fluid embolism with elevation of serum mast cell tryptase. Forensic Sci Int 2002; 126:53-56.
36. Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL, Parsonnet J, Panzer R, Orav EJ, Snydman DR, Black E, Schwartz JS, Moore R, Johnson BL Jr, Platt R: Epidemiology of sepsis syndrome in academic medical centers. JAMA 1997; 278:234-240.
37. Friedman G, Silva E, Vincent JL: Has the mortality of septic shock changed with time. Crit Care Med 1998; 26:2078-2086.
38. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310.
39. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1through 20N Engl J Med 2003; 348: 1546-1554
40. Abraham E, Matthay MA, Dinarello CA, Vincent JL, Cohen J, Opal SM, Glauser M, Parsons P, Fisher CJ Jr, Repine JE: Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit Care Med 2000; 28:232-235.
41. Matot I, Sprung CL: Definition of sepsis. Intensive Care Med 2001; 27(Suppl 1):S3-S9.
42. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709.
43. Czura CJ, Yang H, Amella CA, Tracey KJ: HMGBin the immunology of sepsis (not septic shock) and arthritis. Adv Immunol 2004; 84:181-200.
44. Wang H, Czura CJ, Tracey KJ: Lipid unites disparate syndromes of sepsis. Nat Med 2004; 10:124-125.
45. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel L, Hassan S: The role of inflammation and infection in preterm birth. Semin Reprod Med 2007; 25:21-39.
46. Jalava J, Mantymaa ML, Ekblad U, Toivanen P, Skurnik M, Lassila O, Alanen A: Bacterial 16S rDNA polymerase chain reaction in the detection of intra-amniotic infection. Br J Obstet Gynaecol 1996; 103:664-669.
47. Hitti J, Riley DE, Krohn MA, Hillier SL, Agnew KJ, Krieger JN, Eschenbach DA: Broad-spectrum bacterial rDNA polymerase chain reaction assay for detecting amniotic fluid infection among women in premature labor. Clin Infect Dis 1997; 24:1228-1232.
48. Yoon BH, Romero R, Kim M, Kim EC, Kim T, Park JS, Jun JK: Clinical implications of detection of Ureaplasma urealyticum in the amniotic cavity with the polymerase chain reaction. Am J Obstet Gynecol 2000; 183:1130-1137.
49. Yoon BH, Romero R, Lim JH, Shim SS, Hong JS, Shim JY, Jun JK: The clinical significance of detecting Ureaplasma urealyticum by the polymerase chain reaction in the amniotic fluid of patients with preterm labor. Am J Obstet Gynecol 2003; 189:919-924.
50. Gardella C, Riley DE, Hitti J, Agnew K, Krieger JN, Eschenbach D: Identification and sequencing of bacterial rDNAs in culture-negative amniotic fluid from women in premature labor. Am J Perinatol 2004; 21:319-323.
51. DiGiulio DB, Romero R, Amogan HP, Kusanovic JP, Bik EM, Gotsch F, Kim CJ, Erez O, Edwin S, Relman DA: Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS ONE 2008; 3:e3056.
52. Gibbs RS, Blanco JD, St Clair PJ, Castaneda YS: Quantitative bacteriology of amniotic fluid from women with clinical intraamniotic infection at term. J Infect Dis 1982; 145:1-8.
53. Ulloa L, Tracey KJ: The "ytokine profile" a code for sepsis. Trends Mol Med 2005; 11:56-63.
54. Tracey KJ, Cerami A: Metabolic responses to cachectin/TNF. A brief review. Ann NY Acad Sci 1990; 587:325-331.
55. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987; 330:662-664.
56. Tracey KJ, Cerami A: Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 1993; 9:317-343.
57. Tracey KJ, Cerami A: Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 1994; 45:491-503.
58. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150.
59. Michie HR, Manogue KR, Spriggs DR, Revhaug A, O'Dwyer S, Dinarello CA, Cerami A, Wolff SM, Wilmore DW: Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318:1481-1486.
60. Damas P, Reuter A, Gysen P, Demonty J, Lamy M, Franchimont P: Tumor necrosis factor and interleukin-serum levels during severe sepsis in humans. Crit Care Med 1989; 17:975-978.
61. Fisher CJ Jr, Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slotman GJ, Iberti TJ, Rackow EC, Shapiro MJ, Greenman RL: Recombinant human interleukin receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA 1994; 271:836-843.
62. Abraham E, Laterre PF, Garbino J, Pingleton S, Butler T, Dugernier T, Margolis B, Kudsk K, Zimmerli W, Anderson P, Reynaert M, Lew D, Lesslauer W, Passe S, Cooper P, Burdeska A, Modi M, Leighton A, Salgo M, Van der AP: Lenercept (ptumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,patients. Crit Care Med 2001; 29:503-510.
63. Kindler V, Sappino AP, Grau GE, Piguet PF, Vassalli P: The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989; 56:731-740.
64. Eskandari MK, Bolgos G, Miller C, Nguyen DT, DeForge LE, Remick DG: Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J Immunol 1992; 148:2724-2730.
65. Remick D, Manohar P, Bolgos G, Rodriguez J, Moldawer L, Wollenberg G: Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock 1995; 4:89-95.
66. Esposito E, Cuzzocrea S: TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma. Curr Med Chem 2009; 16: 3152-3167.
67. Taylor PC, Feldmann M: Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat Rev Rheumatol 2009; 5:578-582.
68. Tracey K: The acute and chronic pathophysiologic effects of TNF: mediation of septic shock and wasting (Cachexia). In Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine, B Butler (ed). New York, Raven Press, Ltd, 2007, pp 255-273.
69. Martin PL, Oneda S, Treacy G: Effects of an anti-TNF-alpha monoclonal antibody, administered throughout pregnancy and lactation, on the development of the macaque immune system. Am J Reprod Immunol 2007; 58:138-149.
70. Winger EE, Reed JL: Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am J Reprod Immunol 2008; 60:8-16.
71. Clark DA: Should anti-TNF-alpha therapy be offered to patients with infertility and recurrent spontaneous abortion? Am J Reprod Immunol 2009; 61:107-112
72. Skomsvoll JF, Wallenius M, Koksvik HS, Rodevand E, Salvesen KA, Spigset O, Kvien TK: Drug insight: anti-tumor necrosis factor therapy for inflammatory arthropathies during reproduction, pregnancy and lactation. Nat Clin Pract Rheumatol 2007; 3:156-164.
73. Chaouat G: Comment: primum non-nocere. Am J Reprod Immunol 2008; 60:17-18.
74. Berthelot JM, De BM, Goupille P, Solau-Gervais E, Liote F, Goeb V, Azais I, Martin A, Pallot-Prades B, Maugars Y, Mariette X: Exposition to anti-TNF drugs during pregnancy: outcome of cases and review of the literature. Joint Bone Spine 2009; 76:28-34.
75. Carter JD, Ladhani A, Ricca LR, Valeriano J, Vasey FB: A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database. J Rheumatol 2009; 36:635-641.
76. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ III, Zentella A, Albert JD: Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234:470-474.
77. DeForge LE, Nguyen DT, Kunkel SL, Remick DG: Regulation of the pathophysiology of tumor necrosis factor. J Lab Clin Med 1990; 116:429-438.
78. Calandra T, Baumgartner JD, Grau GE, Wu MM, Lambert PH, Schellekens J, Verhoef J, Glauser MP: Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch JImmunoglobulin Study Group. J Infect Dis 1990; 161:982-987.
79. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E: Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993; 103:565-575.
80. Romero R, Sirtori M, Oyarzun E, Avila C, Mazor M, Callahan R, Sabo V, Athanassiadis AP, Hobbins JC: Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in American Journal of Reproductive Immunology (2010) 113-125
81. Pisa P, Gennene M, Soder O, Ottenhoff T, Hansson M, Kiessling R: Serum tumor necrosis factor levels and disease dissemination in leprosy and leishmaniasis. J Infect Dis 1990; 161:988-991.
82. Sherman ML, Spriggs DR, Arthur KA, Imamura K, Frei E III, Kufe DW: Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism. J Clin Oncol 1988; 6: 344-350.
83. Peetre C, Thysell H, Grubb A, Olsson I: A tumor necrosis factor binding protein is present in human biological fluids. Eur J Haematol 1988; 41:414-419.
84. Laham N, Brennecke SP, Bendtzen K, Rice GE: Tumour necrosis factor alpha during human pregnancy and labour: maternal plasma and amniotic fluid concentrations and release from intrauterine tissues. Eur J Endocrinol 1994; 131: 607-614.
85. Vassiliadis S, Ranella A, Papadimitriou L, Makrygiannakis A, Athanassakis I: Serum levels of proand anti-inflammatory cytokines in non-pregnant women, during pregnancy, labour and abortion. Mediators Inflamm 1998; 7:69-72.
86. Weiyuan Z, Li W: Study of interleukin-and tumor necrosis factor-alpha levels in maternal serum and amniotic fluid of patients with premature rupture of membranes. J Perinat Med 1998; 26:491-494.
87. Nowak M, Oszukowski P, Jaczewski B, Malafiej E, Wierzbicka E, Czichos E, Wilczynski JR, Szpakowski M: [Maternal serum cytokines in labor, pregnancy and chorioamnionitis]. Ginekol Pol 2001; 72: 1158-1162.
88. Gucer F, Balkanli-Kaplan P, Yuksel M, Sayin NC, Yuce MA, Yardim T: Maternal serum levels of tumor necrosis factor-alpha and interleukin-receptor in threatened abortion: a comparison with normal and pathologic pregnancies. Fertil Steril 2001; 76: 707-711.
89. Serin IS, Ozcelik B, Basbug M, Kilic H, Okur D, Erez R: Predictive value of tumor necrosis factor alpha (TNF-alpha) in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2002; 100:143-145.
90. Bahar AM, Ghalib HW, Moosa RA, Zaki ZM, Thomas C, Nabri OA: Maternal serum interleukin-6, interleukin-8, tumor necrosis factor-alpha and interferon-gamma in preterm labor. Acta Obstet Gynecol Scand 2003; 82:543-549.
91. Muzammil S, Singhal U, Gulati R, Bano I: Serum tumor necrosis factor-alpha in pre eclampsia. Indian J Physiol Pharmacol 2005; 49:236-240.
92. Montagnana M, Lippi G, Albiero A, Salvagno GL, Franchi M, Guidi GC: Serum pro-inflammatory cytokines in physiological and pre-eclamptic pregnancies. Gynecol Endocrinol 2008; 24:113-116.
93. Saarelainen H, Valtonen P, Punnonen K, Laitinen T, Raitakari OT, Juonala M, Heiskanen N, Lyyra-Laitinen T, Viikari JS, Heinonen S: Flow mediated vasodilation and circulating concentrations of high sensitive C-reactive protein, interleukin-and tumor necrosis factor-alpha in normal pregnancy The Cardiovascular Risk in Young Finns Study. Clin Physiol Funct Imaging 2009; 29:347-352.
94. Guven MA, Coskun A, Ertas IE, Aral M, Zencirci B, Oksuz H: Association of maternal serum CRP, IL-6, TNF-alpha, homocysteine, folic acid and vitamin Blevels with the severity of preeclampsia and fetal birth weight. Hypertens Pregnancy 2009; 28:190-200.
95. Chedraui P, Lockwood CJ, Schatz F, Buchwalder LF, Schwager G, Guerrero C, Escobar GS, Hidalgo L: Increased plasma soluble fms-like tyrosine kinase and endoglin levels in pregnancies complicated with preeclampsia. J Matern Fetal Neonatal Med 2009; 22:565-570.
96. Valtonen P, Punnonen K, Saarelainen H, Heiskanen N, Raitakari OT, Viikari JS, Lyyra-Laitinen T, Laitinen T, Heinonen S: Maternal serum ADMA is not associated with proinflammatory cytokines or C-reactive protein during normal pregnancy. Cytokine 2009; 46:216-221.
97. Dermitzaki E, Staikou C, Petropoulos G, Rizos D, Siafaka I, Fassoulaki A: A randomized study of maternal serum cytokine levels following cesarean section under general or neuraxial anesthesia. Int J Obstet Anesth 2009; 18:33-37.
98. Steiner PE, Lushbaugh CC: Maternal pulmonary embolism by amniotic fluid as a cause of obstetric shock and unexpected deaths in obstetrics. JAMA 1941; 117:1340-1345.
99. Gross P, Benz E: Pulmonary embolism by amniotic fluid: report of cases with a new diagnostic procedure. Surg, Gynec & Obst 1947; 85:315-320.
100. Hemmings CT: Maternal pulmaonary embolism by contents of the amniotic fluid. Am J Obstet Gynecol 1947; 53:303-306.
101. Shotton D, Taylor C: Pulmonary embolism by amniotic fluid: a report of a fatal case, together with a review of the literature. J Obstet Gynecol Br Emp 1949; 56:46-53.
102. Jennings E, Stofer B: Pulmonary emboli composed of contents of amniotic fluid. Arch Pathol 1948; 45: 616-621.
103. Lushbaugh CC, Steiner PE: Additional observations on maternal pulmonary embolism by amniotic fluid. Am J Obstet Gynecol 1942; 43:833-838.
104. Mallory GK, Blackburn N, Sparling HJ, Nickerson DA: Maternal pulmonary embolism by amniotic fluid; report of three cases and discussion of the literature. N Engl J Med 1950; 243:583-587.
105. Wyatt JP, Goldenberg H: Amniotic fluid embolism: reprot of a fatal case. Arch Pathol (chic) 1948; 45: 366-370.
106. Bouton SM Jr, Saunders JR: Pulmonary embolism of amniotic fluid; report of case with review of literature. Am J Clin Pathol 1951; 21:566-572.
107. Sluder HM, Lock FR: Sudden maternal death associated with amniotic fluid embolism. Am J Obstet Gynecol 1952; 64:118-125.
108. Denniss RG, Goldie W, Polson CJ: Amniotic embolism; a report of two fatalities. J Obstet Gynaecol Br Emp 1954; 61:620-622.
109. Graham HK: Amniotic fluid embolism. Am J Obstet Gynecol 1955; 70:657-659.
110. Stone S, Koucky R, Leland HR: A fatal case of amniotic fluid embolism. Am J Obstet Gynecol 1955; 70:660-662.
111. Scofield GF, Beaird JB Jr: Fatal embolism by amniotic fluid in the lungs; report of a case. Am J Clin Pathol 1957; 28:400-404.
112. Attwood HD, Rome RM: Amniotic embolism and uterine rupture. Aust NZ J Obstet Gynaecol 1963; 3:73-77.
113. Liban E, Raz S: A clinicopathologic study of fourteen cases of amniotic fluid embolism. Am J Clin Pathol 1969; 51:477-486.
114. Peterson EP, Taylor HB: Amniotic fluid embolism. An analysis of cases. Obstet Gynecol 1970; 35: 787-793.
115. Meigs LC: Amniotic fluid embolism. Pulmonary histopathologic findings in a rapidly fatal occurrence of amniotic fluid embolism. Am J Obstet Gynecol 1971; 111:1069-1074.
116. Barrows JJ: A documented case of amniotic fluid embolism presenting as acute fetal distress. Am J Obstet Gynecol 1982; 143:599-600.
117. Mulder JI: Amniotic fluid embolism: an overview and case report. Am J Obstet Gynecol 1985; 152:430-435.
118. McDougall RJ, Duke GJ: Amniotic fluid embolism syndrome: case report and review. Anaesth Intensive Care 1995; 23:735-740.
119. Martin RW: Amniotic fluid embolism. Clin Obstet Gynecol 1996; 39:101-106.
120. Cron RS, Kilkenny GS, Wirthwein C, Evrard JR: Amniotic fluid embolism. Am J Obstet Gynecol 1952; 64:1360-1363.
121. MacMillan D: Experimental amniotic fluid infusion. J Obstet Gynaecol Br Commonw 1968; 75:849-852.
122. Zanotti-Cavazzoni SL, Hollenberg SM: Cardiac dysfunction in severe sepsis and septic shock. Curr Opin Crit Care 2009; 15:392-397.
123. Li XQ, Cao W, Li T, Zeng AG, Hao LL, Zhang XN, Mei QB: Amlodipine inhibits TNF-alpha production and attenuates cardiac dysfunction induced by lipopolysaccharide involving PI3K/Akt pathway. Int Immunopharmacol 2009; 9:1032-1041.
124. Shelley RJ, Dennison AD Jr, Thompson JV: Pulmonary embolism by amniotic fluid. Dis Chest 1959; 36:616-623.
125. Nichols GP, Raney EH: Postpartum confusion: heart failure or amniotic fluid embolism? Arch Intern Med 1966; 117:807-812
126. Lumley J, Owen R, Morgan M: Amniotic fluid embolism. A report of three cases. Anaesthesia 1979; 34:33-36.
127. Guidotti RJ, Grimes DA, Cates W Jr: Fatal amniotic fluid embolism during legally induced abortion, United States, 1to 19Am J Obstet Gynecol 1981; 141:257-261
128. Cromey MG, Taylor PJ, Cumming DC: Probable amniotic fluid embolism after first-trimester pregnancy termination. A case report. J Reprod Med 1983; 28:209-211.
129. Thompson WB, Budd JW: Erroneous diagnoses of amniotic fluid embolism. Am J Obstet Gynecol 1965; 91:606-620.
130. Schwartz IS, Bello GV, Feigin G, Sherman DH: Maternal vernix caseosa peritonitis following premature rupture of fetal membranes. JAMA 1985; 254:948-950.
131. Petroianu GA, Altmannsberger SH, Maleck WH, Assmus HP, Friedberg C, Bergler WF, Rufer R: Meconium and amniotic fluid embolism: effects on coagulation in pregnant mini-pigs. Crit Care Med 1999; 27:348-355.
132. Romero R, Kadar N, Lafreniere D, Durum S, Hobbins JC, Duff GW: Do blood and meconium affect the detection of endotoxin in amniotic fluid with the limulus amebocyte gel clot assay? Am J Perinatol 1987; 4:356-359
133. Petty HR, Kindzelskii AL, Espinoza J, Romero R: Trophoblast contact deactivates human neutrophils. J Immunol 2006; 176:3205-3214.
134. Schneider CL: Obstetric shock; some interdependent problems of coagulation. Obstet Gynecol 1954; 4: 273-294.